ExpreS2ion publishes video presentation
Hørsholm, Denmark, June 1, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CFO Keith Alexander and Vice President of Preclinical Development Mette Thorn in which they provide an update on ExpreS2ion’s breast cancer vaccine candidate, ES2B-C001, is now available on the company’s website.The presentation can be found on the Company’s investor website via the following link: https://investor.expres2ionbio.com/presentations/ Certified AdviserSvensk Kapitalmarknadsgranskning ABTelefon: +46 11 32